Arlington, TX, United States of America

Masood A Chowhan

This inventor holds 41 USPTO granted patents and 29 published patent applications, plus 7 CIPO patents and 26 EPO patents, primarily in Ophthalmic Compositions. Top assignees: Alcon Laboratories, Inc., Alcon Research, Ltd., Alcon, Inc.. Active years: 1991-2018.

USPTO Granted Patents = 41 

% Patents Active = 70.7


 

Average Co-Inventor Count = 2.6

ph-index = 13

Forward Citations = 494(Granted Patents)


Company Filing History:


Years Active: 1991-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Ophthalmic Compositions
Antimicrobial Agents
Polymeric Compounds
Nanoparticle Suspensions
Drug Delivery
Contact Lens Care
Enzyme Compositions
Topical Administration
Self-Preserved Formulations
Infection Treatment
Aqueous Compositions
Demulcents
41 patents (USPTO):Explore Patents

Title: The Inventor Masood A Chowhan: Pioneering Innovations in Arlington

Introduction: Masood A Chowhan is a distinguished inventor based in Arlington, Texas, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Masood A Chowhan holds several patents in the areas of technology and healthcare, showcasing his versatility and ingenuity in developing solutions for complex problems.

Career Highlights: With a career spanning over two decades, Masood A Chowhan has consistently pushed the boundaries of traditional thinking, leading to the development of cutting-edge technologies that have revolutionized industries.

Collaborations: Throughout his career, Masood A Chowhan has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and collaboration.

Conclusion: Masood A Chowhan's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving an indelible mark on the world of technology and beyond.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…